Case Reports in Ophthalmology (Dec 2022)

Preserflo Microshunt Surgery for Ocular Hypertension following Intravitreal Fluocinolone Acetonide Implant Removal: A Case Report

  • Amina Rezkallah,
  • Olivier Loria,
  • Thibaud mathis,
  • Samuel Chacun,
  • Philippe Denis,
  • Laurent Kodjikian

DOI
https://doi.org/10.1159/000527672
Journal volume & issue
Vol. 13, no. 3
pp. 1024 – 1029

Abstract

Read online

Diabetic macular edema (DME) is now a well-known condition for which a number of treatments have been shown to be effective. Intraocular corticosteroids are part of this therapeutic arsenal but are sometimes responsible for ocular hypertension. We describe here the case of a 60-year-old man with a history of bilateral DME who received an intravitreal injection of 190 µg fluocinolone acetonide (FAc) (ILUVIEN®, Alimera Sciences, Alpharetta, GA, USA) who presented a persistent ocular hypertension in one eye despite FAc removal by pars plana vitrectomy and was successfully managed by Preserflo® microshunt surgery.

Keywords